CONSORTIUM

The ProCAncer-I project brings together 20 partners, including PCa centers of reference, world leaders in AI and innovative SMEs, with recognized expertise in their respective domains, with the objective to design, develop and sustain a cloud-based, secure European Image Infrastructure with tools and services for data handling.

Foundation for Research and Technology Hellas (FORTH) COORDINATOR

Greece | Manolis Tsiknakis (Project Coordinator) 

FORTH is the Project Coordinator of ProCAncer-I

RadboudUMC (RUN)

The Netherlands | Jurgen Fütterer

University of Pisa (UNIPI)

Italy | Emanuele Neri

Hacettepe University, School of Medicine, Department of Radiology (HACETTEPE)

Turkey | Deniz Akata

 JCC Diagnostic Imaging (VDC)

Portugal | João Carlos Costa

General Anti-Cancer and Oncological Hospital of Athens, “St. Savvas” (GAONA)

Greece | Vasileios Katsaros

Royal Marsden National Health Service Trust (ICR)

United Kingdom| Dow-Mu Koh

QS Instituto de Investigacion e Innovacion SL (QUIRON)

Spain | Rocio Diaz-Sanchez

Consiglio Nazionale delle Ricerche (CNR)

Italy | Sara Colantonio

ADVANTIS Medical Imaging Single Member PC (ADVANTIS)

Greece | Zoi Giavri

Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF)

Portugal | Nikolaos Papanikolaou

Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana (HULAFE)

Spain | Luis Marti Bonmati

Institut Paoli Calmettes (PCAL)

France | Jochen Walz

Fundacio Institut D’Investigacio Biomedica De Girona Doctor Josep Trueta (IDIBGI)

Spain | Joan C. Vilanova

National Cancer Institute (NCIV)

Lithuania | Jurgita Ušinskienė

Candiolo Cancer Institute, FPO – IRCCS (FPO)

Italy | Daniele Regge

Massachusetts General Hospital (The General Hospital Corp) (QTIM)

USA | Jayashree Kalpathy-Cramer

Biotronics 3D Limited (B3D)

UK | Joao Correia

University of Vienna (UNIVIE)

Austria | Nikolaus Forgó

QUIBIM, Sociedad Limitada (QUIBIM)

Spain | Angel ALBERICH-BAYARRI

Highlights

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα για καλύτερη διάγνωση, θεραπεία και βελτιωμένη ποιότητα ζωής στους ασθενείς που πάσχουν από καρκίνο του προστάτη, δίνει το νέο πανευρωπαϊκό πρόγραμμα ProCAncer-I στο οποίο συμμετέχει και η Ελλάδα καθώς συντονιστής φορέας είναι το Ινστιτούτο Τεχνολογίας και Έρευνας (ΙΤΕ) στην Κρήτη.

Fighting prostate cancer with over 1.5 million MRI images

Fighting prostate cancer with over 1.5 million MRI images

Men die about five years earlier than women across the world. As initiatives to boost awareness of men’s health unfolded in November, an international project is bringing the forefront of AI research to tackle prostate cancer (PC), the second most frequent type of cancer in men and the third most lethal in Europe.

Novartis prostate cancer drug receives U.S. FDA breakthrough designation https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-prostate-cancer-drug-receives-us-fda-breakthrough-designation-2021-06-16/ #prostatecancer

Dr Nickolas Papanikolaou is presenting our project ProCAncer-I at the Health IT Conference on Tuesday 15/6/21. He will talk about the creation of a platfrom containing datasets and AI models for monitoring patients with prostate cancer
@FORTH_ITE https://healthdaily.gr/2021/06/12/tin-triti-anoigei-tin-avlaia-tou-to-4o-health-it-conference/

See the first @ProCAncer_I newsletter. Get to know the ProCAncer-I project, its vision, its anonymization strategy, the legal & ethical issues that were dealt & the MRI based AI tools that will improve the management of patients with prostate cancer. https://tinyurl.com/pci-news01

🤖 #DigitalEU2030
⏰ 1 & 2 June
🖥️ Virtual event

Two days fully dedicated to new #digital technologies, opportunities & next steps to make this Europe's Digital Decade!

Join the debate 👉 http://bit.ly/DigitalEU2030

Load More...

Stay in touch!